1,421
Views
1
CrossRef citations to date
0
Altmetric
ARTICLES

Assessment of cross-reactivity in patients allergic to birch pollen by immunoblotting

, , , , , , , & show all
Pages 445-456 | Received 30 Sep 2011, Accepted 18 Jul 2012, Published online: 16 Aug 2012

Figures & data

Table 1. Concentration of total (tIgE) and allergen-specific IgE (asIgE) in the analysed sera.

Figure 1. Immunoblot analysis. Extracts of plants evoking cross-reactivity were probed with sera from patients and control subjects; selection of immunoblots. (A) Patient 17. S.P., (B), patient 14. C.M., (C), patient 3. F.I., (D), control subject 5. L.J. Bi, extract from birch pollen. Apl, extract from apple peels; Ap, extract from apple pulp; Ca, extract from carrot; Ce, extract from celery. Other details as described in Methods section.
Figure 1. Immunoblot analysis. Extracts of plants evoking cross-reactivity were probed with sera from patients and control subjects; selection of immunoblots. (A) Patient 17. S.P., (B), patient 14. C.M., (C), patient 3. F.I., (D), control subject 5. L.J. Bi, extract from birch pollen. Apl, extract from apple peels; Ap, extract from apple pulp; Ca, extract from carrot; Ce, extract from celery. Other details as described in Methods section.

Table 2. Manifestation of clinical symptoms and the presence of specific IgE antibodies revealing cross-reactivity assessed with the immunoblotting method.

Table 3. Quantification of manifestation of clinical symptoms and the presence of specific IgE antibodies revealing cross-reactivity of the patient and control groups.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.